Neonatal Gene Therapy for Hemophilia B by a Novel Adenovirus Vector Showing Reduced Leaky Expression of Viral Genes

Gene therapy during neonatal and infant stages is a promising approach for hemophilia B, a congenital disorder caused by deficiency of blood coagulation factor IX (FIX). An adenovirus (Ad) vector has high potential for use in neonatal or infant gene therapy for hemophilia B due to its superior trans...

Descripción completa

Detalles Bibliográficos
Autores principales: Iizuka, Shunsuke, Sakurai, Fuminori, Tachibana, Masashi, Ohashi, Kazuo, Mizuguchi, Hiroyuki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Gene & Cell Therapy 2017
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5552065/
https://www.ncbi.nlm.nih.gov/pubmed/28828393
http://dx.doi.org/10.1016/j.omtm.2017.07.001

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5552065/
https://www.ncbi.nlm.nih.gov/pubmed/28828393
http://dx.doi.org/10.1016/j.omtm.2017.07.001

Ejemplares similares